Harmaline hydrochloride
CAS No. 363-11-1
Harmaline hydrochloride ( Harmidine hydrochloride )
Catalog No. M24323 CAS No. 363-11-1
Harmaline hydrochloride?is a?fluorescent?indole?alkaloid?from the group of?harmala alkaloids?and?beta-carbolines.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 45 | In Stock |
|
25MG | 57 | In Stock |
|
50MG | 73 | In Stock |
|
100MG | 131 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHarmaline hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionHarmaline hydrochloride?is a?fluorescent?indole?alkaloid?from the group of?harmala alkaloids?and?beta-carbolines.
-
DescriptionHarmaline hydrochloride?is a?fluorescent?indole?alkaloid?from the group of?harmala alkaloids?and?beta-carbolines. It is the partially?hydrogenated?form of?harmine.Harmaline produces a generalized tremor in normal rats by inducing rhythmic firing of inferior olivary neurons
-
SynonymsHarmidine hydrochloride
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number363-11-1
-
Formula Weight250.7
-
Molecular FormulaC13H15ClN2O
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCC1=NCCC2=C1NC3=C2C=CC(=C3)OC.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Wang Y, Wang C, Jiang C, Zeng H, He X. Novel mechanism of harmaline on inducing G2/M cell cycle arrest and apoptosis by up-regulating Fas/FasL in SGC-7901 cells. Sci Rep. 2015;5:18613. Published 2015 Dec 18. doi:10.1038/srep18613
molnova catalog
related products
-
Chondroitine sulfate
Extracted from shark bone.
-
D-Saccharic acid 1,4...
D-Saccharic acid 1,4-lactone hydrate is a potent β-glucuronidase inhibitor (IC50=48.4 μM). D-Saccharic acid 1,4-lactone hydrate possesses anticarcinogenic, detoxifying, and antioxidant properties.
-
kuwanon G
Kuwanon G as dual inhibitors of PTP1B and α-glucosidase enzymes, as well as insulin sensitizers, it may potentially be utilized as an effective treatment for Type II diabetes mellitus.